Executive record

Darren Cline

Director at Xenon Pharmaceuticals Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:darren-clineVersion: public-0As of: 2026-09-29

Not yet claimed8 published Claims4 sources
  • Executive
  • Director

Key Claims

Biography

Darren Cline serves as Chief Commercial Officer of Xenon Pharmaceuticals Inc. He entered into an employment agreement with the Company dated June 2, 2025.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedChief Commercial Officer · Xenon Pharmaceuticals Inc.
  2. 2026 to end not publishedExecutive title: Chief Commercial Officer · Organization not publishedXENE 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Professional Role: Director at Xenon Pharmaceuticals Inc. · Claim reviewed: Sep 14, 2026

  2. Open source

    sec def 14a · Source published: Apr 22, 2026 · Retrieved: Sep 14, 2026

    Supports 2 claims
    • Professional Role: Chief Commercial Officer at Xenon Pharmaceuticals Inc. · Claim reviewed: Sep 14, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: Sep 14, 2026

  3. XENE 10-K executive officers

    sec filing · Source published: Feb 26, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Xenon Pharmaceuticals · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: Sep 14, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Xenon Pharmaceuticals Inc. · Claim reviewed: Sep 14, 2026